Hydrochlorothiazide

Hydrochlorothiazide is a commonly prescribed diuretic used to treat high blood pressure and fluid retention, and understanding its effects can help in making informed decisions about treatment.

Studies have linked hydrochlorothiazide with an increased risk of skin cancer, particularly squamous cell carcinoma. Additionally, research has indicated that while effective for hypertension, chlorthalidone may be a preferable alternative to hydrochlorothiazide due to its similar efficacy and potentially lower side effect profile. Hydrochlorothiazide is also recognized for its role in preventing kidney stone recurrence when used at appropriate doses.

This medication connects strongly with discussions on skin cancer prevention and management, as well as considerations around hypertension treatment options like chlorthalidone. The evidence base provides useful insights but is limited by the specific conditions and populations studied.

Sources

• [[Hydrochlorothiazide and skin cancer].](https://pubmed.ncbi.nlm.nih.gov/31120217/) (PMID:31120217)
• Hydrochlorothiazide. (PMID:2292804)
• [[Which is better? Chlorthalidone or Hydrochlorothiazide].](https://pubmed.ncbi.nlm.nih.gov/37016241/) (PMID:37016241)
• Valsartan/hydrochlorothiazide: pharmacology and clinical efficacy. (PMID:19689218)
• [[Pharmacogenomics of hydrochlorothiazide].](https://pubmed.ncbi.nlm.nih.gov/19791477/) (PMID:19791477)
• Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence. (PMID:37224210)

_Worker-drafted node, Hermes writer enrichment, pending editorial review._